Johannes L. Peterse - Concepedia

Author

Johannes L. Peterse

Also Known As

C. De Miguel, Franz Schubert, J L Peterse, J Peterse, J. L. PETERSE, J. L. Peterse, J. Peterse, J.L Peterse, J.L. PETERSE, J.L. Peterse

126

Publications

20.2K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute University of Bologna Radboud University Nijmegen

About

Johannes L. Peterse is an author at The Netherlands Cancer Institute specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	45	4.8K
2	Health Sciences	15	15	1.3K
3	Engineering	7	7	953
4	Biostatistics	4	4	776
5	Nursing	1	1	103

Johannes L. Peterse

Publications

17.5K

Citations

H-Index

Page 1

	Year	Citations
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer, New England Journal of Medicine	2002	6.5K
Neu-Protein Overexpression in Breast Cancer Marc J. van de Vijver, Johannes L. Peterse, Wolter J. Mooi, New England Journal of Medicine	1988	858
Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group Nina Bijker, Philip Meijnen, Johannes L. Peterse, Journal of Clinical Oncology	2006	657
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Patrick W.B. Derksen, Xiaoling Liu, Francis N. Saridin, Cancer Cell Breast OncologyAnoikis ResistanceMice LeadsMedicineCancer Biology	2006	590
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials Adri C. Voogd, Maja Nielsen, Johannes L. Peterse, Journal of Clinical Oncology	2001	560
Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853 Nina Bijker, Johannes L. Peterse, Luc Duchateau, Journal of Clinical Oncology	2001	497
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human <i>BRCA1</i> -mutated basal-like breast cancer Xiaoling Liu, Henne Holstege, Hanneke van der Gulden, Proceedings of the National Academy of Sciences	2007	475
Gene expression profiles of primary breast tumors maintained in distant metastases Britta Weigelt, Annuska M. Glas, Lodewyk F.A. Wessels, Proceedings of the National Academy of Sciences Primary Breast TumorsBreast OncologyEngineeringGene Expression ProfilesCancer Biology	2003	431
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Marc J. van de Vijver, R van de Bersselaar, Peter Devilee, Molecular and Cellular Biology OncologyHuman Mammmary TumorsOncogenic AgentMedicineC-erba Oncogene	1987	330
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinomain situ Wiljo J. F. de Leeuw, Geert Berx, Carla B. J. Vos, The Journal of Pathology	1997	303

Page 1